Drug
Cangrelor clinical trials
Also written Kengreal and Kengrexal.
- studies test it
- 26
- open now
- 3
- in phase 3
- 3
- first study started
- 2005
Keep track of what changes. Save the cangrelor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
26 studies that test it; most in 2017 (7)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 7 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 7
- Phase 3
- 3
- Phase 4
- 13
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 18
The Medicines Company (7) · University of Florida (4) · The Royal Wolverhampton Hospitals NHS Trust (1) · Faculty Hospital Kralovske Vinohrady (1) · Chiesi Farmaceutici S.p.A. (1) · University Medical Centre Ljubljana (1) · Insel Gruppe AG, University Hospital Bern (1) · Icahn School of Medicine at Mount Sinai (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cangrelor is read from its arms, and is right about nine times in ten.
Testing it · 26
- The Bridging Antiplatelet Therapy With Cangrelor 2 StudyRecruitingPhase 4University of FloridaNCT07225842Written as Cangrelor
- Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary InterventionRecruitingPhase 4Federico II UniversityNCT06089577Written as Cangrelor 50 MG
- Cangrelor on Top of AnticoagUlation in Patients with MyocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest ReceiVIng VA-ECMORecruitingPhase 2IRCCS San RaffaeleNCT06792643Written as Cangrelor
- REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEntsSuspendedPhase 3Fondation Ophtalmologique Adolphe de RothschildNCT04667078Written as Cangrelor
- The Effect of IV Cangrelor and Oral Ticagrelor StudyCompletedPhase 4The Royal Wolverhampton Hospitals NHS TrustNCT02733341Written as Cangrelor
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial InfarctionCompletedPhase 4Faculty Hospital Kralovske VinohradyNCT03551964Written as Cangrelor
- Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCICompletedPhase 4University of FloridaNCT04668144Written as Cangrelor
- PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatmentCompletedPhase 4University of FloridaNCT04634162Written as Cangrelor
- Cangrelor Neonatal PK/PD and Safety StudyCompletedPhase 1Chiesi Farmaceutici S.p.A.NCT02765633Written as Cangrelor
- Platelet Inhibition to Target Reperfusion InjuryStatus unknownPhase 2National Heart Centre SingaporeNCT03102723Written as Cangrelor
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCICompletedPhase 4University Medical Centre LjubljanaNCT04005729Written as Cangrelor 50 MG
- Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMICompletedPhase 4University of FloridaNCT03247738Written as Cangrelor
- Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct SizeTerminatedPhase 4Khaled Ziada, MDNCT03043274Written as Cangrelor
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.CompletedPhase 4Insel Gruppe AG, University Hospital BernNCT02978040Written as Cangrelor
- Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)Status unknownPhase 2Ospedale Santa Croce-Carle CuneoNCT03862651Written as Cangrelor
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMIStatus unknownPhase 4University of AarhusNCT03182855Written as Cangrelor Tetrasodium
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)CompletedPhase 2Icahn School of Medicine at Mount SinaiNCT01103440Written as Intravenous Glycoprotein inhibitor + ASA, Clopidogrel
- Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMICompletedPhase 4Attikon HospitalNCT02943369Written as Cangrelor 30 mcg/kg bolus + 4 mcg/kg/min
- Add-on Cangrelor in STEMI-triggered Cardiac ArrestStatus unknownPhase 4Medical University of ViennaNCT03273075Written as Cangrelor
- Cangrelor Prasugrel Transition StudyCompletedPhase 2The Medicines CompanyNCT01852019Written as Cangrelor
See all 26 studies that test cangrelor →
Given in every arm · 1 — cangrelor is usual care beside what is tested
Codes
What other systems call cangrelor · ClinicalTrials.gg INT004134
- MeSH (NLM) C117446cangrelorConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6AQ1Y404U7CANGRELORConfirmed FDA, NLM, Wikidata
- RxNorm 1656052Confirmed FDA, Wikidata
- Wikidata Q3655338cangrelorConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76395CangrelorOne source FDA
- DrugBank DB06441One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C117446 | cangrelor | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6AQ1Y404U7 | CANGRELOR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1656052 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3655338 | cangrelor | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76395 | Cangrelor | One source FDA |
| DrugBank | DB06441 | — | One source Wikidata |
Also registered as cangrelor tetrasodium (UNII 2144G00Y7W · RxNorm 1656051).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.